Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: UNIVERSITY OF OKLAHOMA
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2022-09-29 to 2023-09-28
Current total value of award: $100000
Description: ANALYZING CLINICAL OUTCOMES AND GENOMIC DATA OF AMERICAN INDIAN PATIENT POPULATION TREATED WITH IMMUNE CHECKPOINT INHIBITORS FOR VARIOUS CANCERS; BAA PMWP #213.